5-(2-Methylsulfanylethyl)-3-prop-2-enyl-2-sulfanylideneimidazolidin-4-one
Abstract
1. Introduction
2. Results and Discussion
2.1. Synthesis and Spectral Characterization
2.2. Molecular and Crystal Structure Description
3. Materials and Methods
3.1. Chemicals
3.2. Instrumentations
3.3. Synthetic Protocols
3.3.1. General Procedure for the Preparation of l-Methionine Methyl Ester
3.3.2. General Procedure for the Preparation of 5-(2-Methylsulfanylethyl)-3-prop-2-enyl-2-sulfanylideneimidazolidin-4-one
3.3.3. Compound Data of 5-(2-Methylsulfanylethyl)-3-prop-2-enyl-2-sulfanylideneimidazolidin-4-one
3.4. Crystal Structure Determinations
Supplementary Materials
Author Contributions
Funding
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Konnert, L.; Lamaty, F.; Martinez, J.; Colacino, E. Recent Advances in the Synthesis of Hydantoins: The State of the Art of a Valuable Scaffold. Chem. Rev. 2017, 117, 13757–13809. [Google Scholar] [CrossRef] [PubMed]
- Cho, S.H.; Kim, S.H.; Shin, D. Recent Applications of Hydantoin and Thiohydantoin in Medicinal Chemistry. Eur. J. Med. Chem. 2019, 164, 517–545. [Google Scholar] [CrossRef] [PubMed]
- Gawas, P.P.; Ramakrishna, B.; Veeraiah, N.; Nutalapati, V. Multifunctional Hydantoins: Recent Advances in Optoelectronics and Medicinal Drugs from Academia to the Chemical Industry. J. Mater. Chem. C 2021, 9, 16341–16377. [Google Scholar] [CrossRef]
- Metwally, M.A.; Abdel-Latif, E. Thiohydantoins: Synthetic Strategies and Chemical Reactions. J. Sulfur Chem. 2012, 33, 229–257. [Google Scholar] [CrossRef]
- Šmit, B.; Rodić, M.; Pavlović, R. Synthesis of Angularly Fused (Homo)Triquinane-Type Hydantoins as Precursors of Bicyclic Prolines. Synth. 2015, 48, 387–393. [Google Scholar] [CrossRef]
- de Carvalho, P.G.C.; Ribeiro, J.M.; Garbin, R.P.B.; Nakazato, G.; Yamada Ogatta, S.F.; de Fátima, Â.; de Lima Ferreira Bispo, M.; Macedo, F. Synthesis and Antimicrobial Activity of Thiohydantoins Obtained from L-Amino Acids. Lett. Drug Des. Discov. 2020, 17, 94–102. [Google Scholar] [CrossRef]
- Rajic, Z.; Zorc, B.; Raic-Malic, S.; Ester, K.; Kralj, M.; Pavelic, K.; Balzarini, J.; De Clercq, E.; Mintas, M. Hydantoin Derivatives of L- and D-Amino Acids: Synthesis and Evaluation of Their Antiviral and Antitumoral Activity. Molecules 2006, 11, 837–848. [Google Scholar] [CrossRef] [PubMed]
- Elbadawi, M.M.; Khodair, A.I.; Awad, M.K.; Kassab, S.E.; Elsaady, M.T.; Abdellatif, K.R.A. Design, Synthesis and Biological Evaluation of Novel Thiohydantoin Derivatives as Antiproliferative Agents: A Combined Experimental and Theoretical Assessments. J. Mol. Struct. 2022, 1249, 131574. [Google Scholar] [CrossRef]
- Takahashi, A.; Matsuoka, H.; Uda, Y. Antimutagenicity of 3-Allyl-5-Substituted 2-Thiohydantoins Derived from Allyl Isothiocyanate and Amino Acids in Salmonella Assay. Environ. Mutagen Res. 2004, 26, 1–8. [Google Scholar] [CrossRef]
- Paronikyan, R.; Grigoryan, A.; Barkhudaryants, I.; Arshakyan, L.; Harutyunyan, A. Synthesis and Neurotropic Activity of New Derivatives of Some Amino Acid Hydantoins and Their Lithium Salts. Bioact. Compd. Health Dis. 2024, 7, 274–288. [Google Scholar] [CrossRef]
- Haslak, Z.P.; Agopcan Cinar, S.; Sarigul Ozbek, S.; Monard, G.; Dogan, I.; Aviyente, V. Elucidation of the Atroposelectivity in the Synthesis of Axially Chiral Thiohydantoin Derivatives. Org. Biomol. Chem. 2020, 18, 2233–2241. [Google Scholar] [CrossRef] [PubMed]
- Bruno, I.J.; Cole, J.C.; Kessler, M.; Luo, J.; Motherwell, W.D.S.; Purkis, L.H.; Smith, B.R.; Taylor, R.; Cooper, R.I.; Harris, S.E.; et al. Retrieval of Crystallographically-Derived Molecular Geometry Information. J. Chem. Inf. Comput. Sci. 2004, 44, 2133–2144. [Google Scholar] [CrossRef] [PubMed]
- Jelsch, C.; Ejsmont, K.; Huder, L. The Enrichment Ratio of Atomic Contacts in Crystals, an Indicator Derived from the Hirshfeld Surface Analysis. IUCrJ 2014, 1, 119–128. [Google Scholar] [CrossRef] [PubMed]
- Mackenzie, C.F.; Spackman, P.R.; Jayatilaka, D.; Spackman, M.A. CrystalExplorer Model Energies and Energy Frameworks: Extension to Metal Coordination Compounds, Organic Salts, Solvates and Open-Shell Systems. IUCrJ 2017, 4, 575–587. [Google Scholar] [CrossRef] [PubMed]
- Reyes, S.; Burgess, K. On Formation of Thiohydantoins from Amino Acids under Acylation Conditions. J. Org. Chem. 2006, 71, 2507–2509. [Google Scholar] [CrossRef] [PubMed]
- Rigaku Oxford Diffraction, 1.171.38.46. CrysAlisPro Software System. Rigaku Corporation: Wroclaw, Poland, 2019.
- Sheldrick, G.M. SHELXT–Integrated Space-Group and Crystal-Structure Determination. Acta Crystallogr. Sect. A Found. Adv. 2015, 71, 3–8. [Google Scholar] [CrossRef]
- Sheldrick, G.M. Crystal Structure Refinement with SHELXL. Acta Crystallogr. Sect. C Struct. Chem. 2015, 71, 3–8. [Google Scholar] [CrossRef]
- Spackman, P.R.; Turner, M.J.; McKinnon, J.J.; Wolff, S.K.; Grimwood, D.J.; Jayatilaka, D.; Spackman, M.A. CrystalExplorer: A Program for Hirshfeld Surface Analysis, Visualization and Quantitative Analysis of Molecular Crystals. J. Appl. Crystallogr. 2021, 54, 1006–1011. [Google Scholar] [CrossRef] [PubMed]
- Jayatilaka, D.; Grimwood, D.J. Tonto: A Fortran Based Object-Oriented System for Quantum Chemistry and Crystallography. In Computational Science—ICCS 2003. ICCS 2003. Lecture Notes in Computer Science; Sloot, P.M.A., Abramson, D., Bogdanov, A.V., Gorbachev, Y.E., Dongarra, J.J., Zomaya, A.Y., Eds.; Springer: Berlin/Heidelberg, Germany, 2003; Volume 2660, pp. 142–151. [Google Scholar]
N | Symmetry Operation | R/Å | E/kJ mol−1 | ||||
---|---|---|---|---|---|---|---|
Eele | Epol | Edis | Erep | Etot | |||
1 | −x, −y, −z | 6.13 | −71.4 | −14.3 | −23.7 | 90.8 | −50.6 |
1 | −x, −y, −z | 6.39 | −17.0 | −5.6 | −28.7 | 15.1 | −37.8 |
2 | x, y, z | 5.32 | −11.4 | −5.8 | −34.1 | 24.0 | −31.2 |
1 | −x, −y, −z | 4.94 | −15.5 | −4.0 | −30.6 | 30.5 | −27.2 |
1 | −x, −y, −z | 9.78 | −14.0 | −2.9 | −17.3 | 18.7 | −20.4 |
1 | −x, −y, −z | 6.58 | 1.2 | −2.0 | −22.0 | 9.7 | −13.4 |
1 | −x, −y, −z | 12.13 | −4.2 | −0.7 | −7.6 | 6.4 | −7.6 |
2 | x, y, z | 10.93 | −0.0 | −0.3 | −5.5 | 3.3 | −2.9 |
2 | x, y, z | 11.16 | 0.1 | −0.1 | −2.3 | 0.3 | −1.8 |
1 | −x, −y, −z | 10.77 | 1.9 | −0.2 | −4.1 | 0.3 | −1.5 |
1 | −x, −y, −z | 12.95 | 2.0 | −0.4 | −3.2 | 1.9 | 0.2 |
Crystal Data | |
---|---|
Chemical formula | C9H14N2OS2 |
Mr | 230.34 |
Crystal system | Triclinic |
Space group | P |
Temperature, K | 295 |
a/Å | 5.3161 (4) |
b/Å | 10.4776 (7) |
c/Å | 10.9253 (9) |
α/° | 100.211 (6) |
β/° | 101.448 (7) |
γ/° | 95.476 (6) |
V/Å3 | 581.58 (8) |
Z | 2 |
Radiation type | Mo Kα |
µ/mm−1 | 0.43 |
Crystal size, mm | 0.77 × 0.38 × 0.24 |
Data collection | |
Diffractometer | Gemini S (Oxford Diffraction) |
Absorption correction | Analytical |
Tmin, Tmax | 0.787, 0.924 |
No. of measured reflections | 8315 |
No. of independent reflections | 2721 |
No. of observed [I > 2σ(I)] reflections | 2229 |
Rint | 0.027 |
(sin θ/λ)max/Å−1 | 0.683 |
Refinement | |
R[F2 > 2σ(F2)] | 0.046 |
wR(F2) | 0.134 |
S | 1.020 |
No. of reflections | 2721 |
No. of parameters | 132 |
H-atom treatment | Mixed |
Δρmax, Δρmin/e Å−3 | 0.60 −0.53 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Stanić, P.; Rodić, M.V.; Šmit, B. 5-(2-Methylsulfanylethyl)-3-prop-2-enyl-2-sulfanylideneimidazolidin-4-one. Molbank 2025, 2025, M2057. https://doi.org/10.3390/M2057
Stanić P, Rodić MV, Šmit B. 5-(2-Methylsulfanylethyl)-3-prop-2-enyl-2-sulfanylideneimidazolidin-4-one. Molbank. 2025; 2025(3):M2057. https://doi.org/10.3390/M2057
Chicago/Turabian StyleStanić, Petar, Marko V. Rodić, and Biljana Šmit. 2025. "5-(2-Methylsulfanylethyl)-3-prop-2-enyl-2-sulfanylideneimidazolidin-4-one" Molbank 2025, no. 3: M2057. https://doi.org/10.3390/M2057
APA StyleStanić, P., Rodić, M. V., & Šmit, B. (2025). 5-(2-Methylsulfanylethyl)-3-prop-2-enyl-2-sulfanylideneimidazolidin-4-one. Molbank, 2025(3), M2057. https://doi.org/10.3390/M2057